Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173820 | SCV000224974 | uncertain significance | not provided | 2014-07-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763727 | SCV000894611 | uncertain significance | Homocystinuria due to methylene tetrahydrofolate reductase deficiency; Neural tube defects, folate-sensitive; Schizophrenia; Thrombophilia due to thrombin defect | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081882 | SCV001002447 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000173820 | SCV001370926 | uncertain significance | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001081882 | SCV003808987 | uncertain significance | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2022-03-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001081882 | SCV002094625 | likely benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2020-01-13 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003947466 | SCV004762737 | likely benign | MTHFR-related disorder | 2022-04-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |